Maple Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Sell |
8,393
-825
| -9% | -$95.2K | 0.07% | 55 |
|
|
2025
Q4 | $970K | Buy |
9,218
+354
| +4% | +$33.2K | 0.06% | 55 |
|
|
2025
Q3 | $744K | Sell |
8,864
-1,475
| -14% | -$121K | 0.05% | 61 |
|
|
2025
Q2 | $818K | Sell |
10,339
-1,913
| -16% | -$152K | 0.06% | 63 |
|
|
2025
Q1 | $1.1M | Sell |
12,252
-1,341
| -10% | -$125K | 0.09% | 54 |
|
|
2024
Q4 | $1.35M | Sell |
13,593
-619
| -4% | -$63.8K | 0.1% | 50 |
|
|
2024
Q3 | $1.61M | Sell |
14,212
-476
| -3% | -$56.6K | 0.12% | 46 |
|
|
2024
Q2 | $1.82M | Sell |
14,688
-591
| -4% | -$76.1K | 0.15% | 44 |
|
|
2024
Q1 | $2.02M | Sell |
15,279
-464
| -3% | -$57.2K | 0.18% | 38 |
|
|
2023
Q4 | $1.72M | Buy |
15,743
+575
| +4% | +$59.7K | 0.17% | 38 |
|
|
2023
Q3 | $1.56M | Buy |
15,168
+689
| +5% | +$74.3K | 0.18% | 43 |
|
|
2023
Q2 | $1.67M | Sell |
14,479
-507
| -3% | -$57.6K | 0.18% | 44 |
|
|
2023
Q1 | $1.59M | Buy |
14,986
+379
| +3% | +$40.9K | 0.19% | 44 |
|
|
2022
Q4 | $1.62M | Buy |
14,607
+325
| +2% | +$33.2K | 0.21% | 44 |
|
|
2022
Q3 | $1.43M | Sell |
14,282
-447
| -3% | -$39.9K | 0.18% | 46 |
|
|
2022
Q2 | $1.34M | Sell |
14,729
-1,453
| -9% | -$129K | 0.18% | 47 |
|
|
2022
Q1 | $1.33M | Sell |
16,182
-999
| -6% | -$78.8K | 0.16% | 48 |
|
|
2021
Q4 | $1.32M | Sell |
17,181
-226
| -1% | -$18K | 0.14% | 48 |
|
|
2021
Q3 | $1.31M | Sell |
17,407
-832
| -5% | -$63.3K | 0.17% | 48 |
|
|
2021
Q2 | $1.4M | Sell |
18,239
-2,229
| -11% | -$166K | 0.17% | 48 |
|
|
2021
Q1 | $1.51M | Sell |
20,468
-954
| -4% | -$70.4K | 0.22% | 45 |
|
|
2020
Q4 | $1.67M | Sell |
21,422
-1,549
| -7% | -$118K | 0.26% | 46 |
|
|
2020
Q3 | $1.78M | Sell |
22,971
-246
| -1% | -$19.3K | 0.29% | 45 |
|
|
2020
Q2 | $1.71M | Sell |
23,217
-862
| -4% | -$64.9K | 0.34% | 46 |
|
|
2020
Q1 | $1.77M | Sell |
24,079
-747
| -3% | -$58.7K | 0.44% | 39 |
|
|
2019
Q4 | $2.15M | Buy |
24,826
+834
| +3% | +$68.5K | 0.42% | 44 |
|
|
2019
Q3 | $1.93M | Buy |
23,992
+355
| +2% | +$28.5K | 0.41% | 44 |
|
|
2019
Q2 | $1.89M | Buy |
23,637
+1,435
| +6% | +$110K | 0.42% | 43 |
|
|
2019
Q1 | $1.76M | Sell |
22,202
-368
| -2% | -$27.5K | 0.41% | 42 |
|
|
2018
Q4 | $1.65M | Buy |
22,570
+154
| +0.7% | +$10.9K | 0.42% | 44 |
|
|
2018
Q3 | $1.52M | Sell |
22,416
-2,305
| -9% | -$147K | 0.34% | 45 |
|
|
2018
Q2 | $1.43M | Sell |
24,721
-3,825
| -13% | -$216K | 0.35% | 46 |
|
|
2018
Q1 | $1.48M | Sell |
28,546
-1,133
| -4% | -$61.2K | 0.37% | 50 |
|
|
2017
Q4 | $1.59M | Buy |
29,679
+75
| +0.3% | +$4.16K | 0.41% | 47 |
|
|
2017
Q3 | $1.81M | Buy |
29,604
+1,074
| +4% | +$65.1K | 0.49% | 45 |
|
|
2017
Q2 | $1.75M | Buy |
28,530
+1,090
| +4% | +$66.4K | 0.5% | 45 |
|
|
2017
Q1 | $1.66M | Buy |
27,440
+1
| +0% | +$61 | 0.49% | 49 |
|
|
2016
Q4 | $1.54M | Buy |
27,439
+353
| +1% | +$20.7K | 0.48% | 51 |
|
|
2016
Q3 | $1.61M | Buy |
27,086
+791
| +3% | +$46.3K | 0.52% | 49 |
|
|
2016
Q2 | $1.45M | Sell |
26,295
-329
| -1% | -$17.5K | 0.53% | 49 |
|
|
2016
Q1 | $1.34M | Sell |
26,624
-735
| -3% | -$36K | 0.5% | 49 |
|
|
2015
Q4 | $1.38M | Buy |
27,359
+1,252
| +5% | +$63.1K | 0.49% | 52 |
|
|
2015
Q3 | $1.23M | Buy |
26,107
+991
| +4% | +$52.6K | 0.46% | 56 |
|
|
2015
Q2 | $1.36M | Buy |
25,116
+203
| +0.8% | +$11.4K | 0.47% | 55 |
|
|
2015
Q1 | $1.37M | Buy |
24,913
+2,716
| +12% | +$154K | 0.48% | 53 |
|
|
2014
Q4 | $1.2M | Buy |
22,197
+1,276
| +6% | +$71.1K | 0.44% | 56 |
|
|
2014
Q3 | $1.18M | Buy |
20,921
+951
| +5% | +$53.4K | 0.45% | 58 |
|
|
2014
Q2 | $1.1M | Buy |
19,970
+1,965
| +11% | +$107K | 0.4% | 60 |
|
|
2014
Q1 | $975K | Buy |
18,005
+315
| +2% | +$16.3K | 0.38% | 66 |
|
|
2013
Q4 | $845K | Buy |
17,690
+183
| +1% | +$8.37K | 0.34% | 64 |
|
|
2013
Q3 | $795K | Buy |
17,507
+556
| +3% | +$25.4K | 0.35% | 63 |
|
|
2013
Q2 | $751K | Buy |
+16,951
| New | +$757K | 0.34% | 65 |
|
Other funds holding MRK
VCM
VPM
Maple Capital Management's MRK Position: Q1 2026 in Review
Maple Capital Management reduced its Merck (MRK) stake by 8.9% in Q1 2026, selling an estimated $95.2K and leaving 8,393 shares worth $1.01M. The position accounts for 0.07% of the portfolio, ranked #55.
Maple Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.15M in Q4 2019. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Maple Capital Management held 8,393 shares of Merck worth $1.01M as of Q1 2026.
- Maple Capital Management sold 825 Merck shares in Q1 2026, an estimated $95.2K.
- Merck made up 0.07% of Maple Capital Management's portfolio in Q1 2026, its #55 holding.
- Maple Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Maple Capital Management's Merck position peaked at $2.15M in Q4 2019.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.